The Cholangiocarcinoma Foundation and Komodo Health announced an agreement linking a cancer advocacy group with a healthcare analytics and insights delivery company to advance the treatment of cholangiocarcinoma.
As NCI paylines drop to 4%, cancer centers are tapping into their institutional funds to provide “bridge funding,” typically in $50,000 to $100,000 increments, to enable investigators to keep their labs open until better times return—next year God willing.
